Related Experiment Video
Updated: Aug 29, 2025

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Ischemic colitis as a cause of severe hematochezia: A mini review
Usah Khrucharoen1,2,3,4, Dennis M Jensen1,2,3,4
1CURE Hemostasis Research Unit and the UCLA Digestive Diseases Research Core Center (UCLA: DDRCC), Los Angeles, CA, USA.
Insights
Ischemic colitis (IC) is a frequent cause of severe lower gastrointestinal bleeding in seniors. Most patients with severe hematochezia from IC can be treated non-surgically, but surgery indicates worse outcomes.
Area of Science:
- Gastroenterology
- Colorectal Surgery
- Internal Medicine
Background:
- Ischemic colitis (IC) is a significant cause of severe lower gastrointestinal bleeding (LGIB), particularly in the elderly population.
- Limited literature exists on IC as a primary cause of severe LGIB, necessitating a comprehensive review.
Purpose of the Study:
- To review the diagnosis, colonoscopic findings, medical treatment strategies, and clinical outcomes for patients presenting with severe hematochezia due to IC.
- To evaluate the efficacy and safety of colonoscopic hemostasis and surgical interventions in managing IC-related severe bleeding.
Main Methods:
- Literature review focusing on diagnosis, colonoscopic findings, and treatment modalities for ischemic colitis.
- Analysis of outcomes based on treatment approach (medical vs. surgical) and patient setting (inpatient vs. outpatient).
Main Results:
- The majority of severe hematochezia cases from IC are manageable with medical treatment.
- Colonoscopic hemostasis using hemoclips is a safe and feasible option for focal ischemic ulcers with major hemorrhage stigmata.
- Colon surgery is reserved for patients refractory to medical treatment, experiencing ongoing severe bleeding, clinical deterioration, or peritoneal signs, and is associated with higher morbidity.
Conclusions:
- Medical management is effective for most patients with severe hematochezia from IC.
- Colonoscopic interventions offer a viable alternative for managing active bleeding in focal ischemic ulcers.
- Surgical intervention for IC is associated with poorer clinical outcomes compared to medical management, highlighting the importance of early and appropriate treatment strategies.
Abstract:
Ischemic colitis (IC) is a common cause of severe lower gastrointestinal bleeding (LGIB) in the elderly. There are very few studies of patients with IC as a cause of severe LGIB in the literature. This article aims to review diagnosis, colonoscopic findings, medical treatment, and outcomes of patients with IC as a cause of severe hematochezia. The majority of IC patients with severe hematochezia can be successfully managed with medical treatment. Colonoscopic hemostasis with hemoclips is safe and feasible in treating major stigmata of recent hemorrhage in focal ischemic ulcers. Colon surgery is indicated in patients who fail medical treatment and/or have severe ongoing bleeding, clinical deterioration, or peritoneal signs. Overall, the morbidity rates in patients with IC range from 10% to 79%. Clinical outcomes in patients who need colon surgery for IC are worse than those treated with medical management. Patients who develop hematochezia from IC during hospitalization for other medical conditions have worse clinical outcomes than those with an outpatient start of bleeding. Further research is warranted for the prevention, early diagnosis, and treatment of patients with severe hematochezia from IC.
Related Concept Videos
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Drugs for Treatment of Ulcerative Colitis in IBD
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Esophageal Varices-II: Clinical Features and Management
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
Esophageal Varices-I: Introduction

